questionsmedicales.fr
Maladies de l'appareil respiratoire
Maladies pulmonaires
Poumon hyperclair
Poumon hyperclair : Questions médicales fréquentes
Termes MeSH sélectionnés :
{
"@context": "https://schema.org",
"@graph": [
{
"@type": "MedicalWebPage",
"name": "Poumon hyperclair : Questions médicales les plus fréquentes",
"headline": "Poumon hyperclair : Comprendre les symptômes, diagnostics et traitements",
"description": "Guide complet et accessible sur les Poumon hyperclair : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.",
"datePublished": "2024-02-19",
"dateModified": "2025-02-13",
"inLanguage": "fr",
"medicalAudience": [
{
"@type": "MedicalAudience",
"name": "Grand public",
"audienceType": "Patient",
"healthCondition": {
"@type": "MedicalCondition",
"name": "Poumon hyperclair"
},
"suggestedMinAge": 18,
"suggestedGender": "unisex"
},
{
"@type": "MedicalAudience",
"name": "Médecins",
"audienceType": "Physician",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "France"
}
},
{
"@type": "MedicalAudience",
"name": "Chercheurs",
"audienceType": "Researcher",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "International"
}
}
],
"reviewedBy": {
"@type": "Person",
"name": "Dr Olivier Menir",
"jobTitle": "Expert en Médecine",
"description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale",
"url": "/static/pages/docteur-olivier-menir.html",
"alumniOf": {
"@type": "EducationalOrganization",
"name": "Université Paris Descartes"
}
},
"isPartOf": {
"@type": "MedicalWebPage",
"name": "Maladies pulmonaires",
"url": "https://questionsmedicales.fr/mesh/D008171",
"about": {
"@type": "MedicalCondition",
"name": "Maladies pulmonaires",
"code": {
"@type": "MedicalCode",
"code": "D008171",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "C08.381"
}
}
},
"about": {
"@type": "MedicalCondition",
"name": "Poumon hyperclair",
"alternateName": "Lung, Hyperlucent",
"code": {
"@type": "MedicalCode",
"code": "D019568",
"codingSystem": "MeSH"
}
},
"author": [
{
"@type": "Person",
"name": "Hiromichi Niikawa",
"url": "https://questionsmedicales.fr/author/Hiromichi%20Niikawa",
"affiliation": {
"@type": "Organization",
"name": "Department of Thoracic Surgery, Institute of Development, Aging and Cancer, Tohoku University, 4-1 Seiryomachi, Aobaku, Sendai, 980-8575, Japan."
}
},
{
"@type": "Person",
"name": "Kenneth R McCurry",
"url": "https://questionsmedicales.fr/author/Kenneth%20R%20McCurry",
"affiliation": {
"@type": "Organization",
"name": "Department of Pathobiology, Lerner Research Institute, Cleveland Clinic, Cleveland, OH, USA."
}
},
{
"@type": "Person",
"name": "Joshua M Diamond",
"url": "https://questionsmedicales.fr/author/Joshua%20M%20Diamond",
"affiliation": {
"@type": "Organization",
"name": "Division of Pulmonary, Allergy and Critical Care Medicine, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, Pennsylvania."
}
},
{
"@type": "Person",
"name": "Hisashi Oishi",
"url": "https://questionsmedicales.fr/author/Hisashi%20Oishi",
"affiliation": {
"@type": "Organization",
"name": "Department of Thoracic Surgery, Institute of Development, Aging and Cancer, Tohoku University, 4-1 Seiryomachi, Aobaku, Sendai, 980-8575, Japan. hisashi.oishi.c7@tohoku.ac.jp."
}
},
{
"@type": "Person",
"name": "Takashi Hirama",
"url": "https://questionsmedicales.fr/author/Takashi%20Hirama",
"affiliation": {
"@type": "Organization",
"name": "Department of Thoracic Surgery, Institute of Development, Aging and Cancer, Tohoku University, 4-1 Seiryomachi, Aobaku, Sendai, 980-8575, Japan."
}
}
],
"citation": [
{
"@type": "ScholarlyArticle",
"name": "Cognitive and functional connectivity impairment in post-COVID-19 olfactory dysfunction.",
"datePublished": "2023-04-17",
"url": "https://questionsmedicales.fr/article/37104928",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1016/j.nicl.2023.103410"
}
},
{
"@type": "ScholarlyArticle",
"name": "Recent advances on the molecular mechanisms of exercise-induced improvements of cognitive dysfunction.",
"datePublished": "2023-02-27",
"url": "https://questionsmedicales.fr/article/36850004",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1186/s40035-023-00341-5"
}
},
{
"@type": "ScholarlyArticle",
"name": "Integrative Brain Network and Salience Models of Psychopathology and Cognitive Dysfunction in Schizophrenia.",
"datePublished": "2022-10-04",
"url": "https://questionsmedicales.fr/article/36702660",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1016/j.biopsych.2022.09.029"
}
},
{
"@type": "ScholarlyArticle",
"name": "The quantitative analysis of EEG during resting and cognitive states related to neurological dysfunctions and cognitive impairments in methamphetamine abusers.",
"datePublished": "2022-09-10",
"url": "https://questionsmedicales.fr/article/36100041",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1016/j.neulet.2022.136870"
}
},
{
"@type": "ScholarlyArticle",
"name": "Cognitive dysfunction and psychopathology: a cohort study of adults with intellectual developmental disorder.",
"datePublished": "2023-09-10",
"url": "https://questionsmedicales.fr/article/37690814",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1111/jir.13077"
}
}
],
"breadcrumb": {
"@type": "BreadcrumbList",
"itemListElement": [
{
"@type": "ListItem",
"position": 1,
"name": "questionsmedicales.fr",
"item": "https://questionsmedicales.fr"
},
{
"@type": "ListItem",
"position": 2,
"name": "Maladies de l'appareil respiratoire",
"item": "https://questionsmedicales.fr/mesh/D012140"
},
{
"@type": "ListItem",
"position": 3,
"name": "Maladies pulmonaires",
"item": "https://questionsmedicales.fr/mesh/D008171"
},
{
"@type": "ListItem",
"position": 4,
"name": "Poumon hyperclair",
"item": "https://questionsmedicales.fr/mesh/D019568"
}
]
}
},
{
"@type": "MedicalWebPage",
"name": "Article complet : Poumon hyperclair - Questions et réponses",
"headline": "Questions et réponses médicales fréquentes sur Poumon hyperclair",
"description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.",
"datePublished": "2025-05-08",
"inLanguage": "fr",
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Diagnostic",
"headline": "Diagnostic sur Poumon hyperclair",
"description": "Comment diagnostiquer un poumon hyperclair ?\nQuels examens complémentaires sont utiles ?\nQuels signes radiologiques indiquent un poumon hyperclair ?\nLe poumon hyperclair est-il toujours pathologique ?\nQuel rôle joue l'anamnèse dans le diagnostic ?",
"url": "https://questionsmedicales.fr/mesh/D019568?mesh_terms=Cognitive+Dysfunction&page=5#section-diagnostic"
},
{
"@type": "MedicalWebPage",
"name": "Symptômes",
"headline": "Symptômes sur Poumon hyperclair",
"description": "Quels symptômes sont associés au poumon hyperclair ?\nLe poumon hyperclair provoque-t-il des douleurs ?\nY a-t-il des symptômes spécifiques chez les enfants ?\nComment la toux se manifeste-t-elle ?\nLe poumon hyperclair est-il asymptomatique ?",
"url": "https://questionsmedicales.fr/mesh/D019568?mesh_terms=Cognitive+Dysfunction&page=5#section-symptômes"
},
{
"@type": "MedicalWebPage",
"name": "Prévention",
"headline": "Prévention sur Poumon hyperclair",
"description": "Comment prévenir le poumon hyperclair ?\nY a-t-il des vaccinations recommandées ?\nComment surveiller la santé pulmonaire ?\nLes exercices respiratoires aident-ils ?\nQuelles habitudes de vie adopter ?",
"url": "https://questionsmedicales.fr/mesh/D019568?mesh_terms=Cognitive+Dysfunction&page=5#section-prévention"
},
{
"@type": "MedicalWebPage",
"name": "Traitements",
"headline": "Traitements sur Poumon hyperclair",
"description": "Quel traitement pour un poumon hyperclair ?\nLes antibiotiques sont-ils nécessaires ?\nQuand envisager une intervention chirurgicale ?\nLes corticostéroïdes sont-ils efficaces ?\nComment gérer les symptômes respiratoires ?",
"url": "https://questionsmedicales.fr/mesh/D019568?mesh_terms=Cognitive+Dysfunction&page=5#section-traitements"
},
{
"@type": "MedicalWebPage",
"name": "Complications",
"headline": "Complications sur Poumon hyperclair",
"description": "Quelles complications peuvent survenir ?\nLe poumon hyperclair peut-il entraîner des infections ?\nComment gérer les complications ?\nLe poumon hyperclair est-il réversible ?\nQuels sont les risques à long terme ?",
"url": "https://questionsmedicales.fr/mesh/D019568?mesh_terms=Cognitive+Dysfunction&page=5#section-complications"
},
{
"@type": "MedicalWebPage",
"name": "Facteurs de risque",
"headline": "Facteurs de risque sur Poumon hyperclair",
"description": "Quels sont les principaux facteurs de risque ?\nL'âge influence-t-il le risque ?\nLes maladies pulmonaires prédisposent-elles ?\nLe mode de vie joue-t-il un rôle ?\nLes allergies sont-elles un facteur ?",
"url": "https://questionsmedicales.fr/mesh/D019568?mesh_terms=Cognitive+Dysfunction&page=5#section-facteurs de risque"
}
]
},
{
"@type": "FAQPage",
"mainEntity": [
{
"@type": "Question",
"name": "Comment diagnostiquer un poumon hyperclair ?",
"position": 1,
"acceptedAnswer": {
"@type": "Answer",
"text": "Le diagnostic se fait par radiographie thoracique et éventuellement par scanner."
}
},
{
"@type": "Question",
"name": "Quels examens complémentaires sont utiles ?",
"position": 2,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des tests fonctionnels respiratoires et une tomodensitométrie peuvent être réalisés."
}
},
{
"@type": "Question",
"name": "Quels signes radiologiques indiquent un poumon hyperclair ?",
"position": 3,
"acceptedAnswer": {
"@type": "Answer",
"text": "Une diminution de la densité pulmonaire et une augmentation de la transparence sont observées."
}
},
{
"@type": "Question",
"name": "Le poumon hyperclair est-il toujours pathologique ?",
"position": 4,
"acceptedAnswer": {
"@type": "Answer",
"text": "Non, il peut être physiologique chez les jeunes enfants ou en cas d'hyperinflation."
}
},
{
"@type": "Question",
"name": "Quel rôle joue l'anamnèse dans le diagnostic ?",
"position": 5,
"acceptedAnswer": {
"@type": "Answer",
"text": "L'anamnèse aide à identifier des antécédents de maladies respiratoires ou d'exposition."
}
},
{
"@type": "Question",
"name": "Quels symptômes sont associés au poumon hyperclair ?",
"position": 6,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les symptômes peuvent inclure une dyspnée, une toux ou des douleurs thoraciques."
}
},
{
"@type": "Question",
"name": "Le poumon hyperclair provoque-t-il des douleurs ?",
"position": 7,
"acceptedAnswer": {
"@type": "Answer",
"text": "Pas directement, mais des douleurs peuvent survenir en raison de maladies sous-jacentes."
}
},
{
"@type": "Question",
"name": "Y a-t-il des symptômes spécifiques chez les enfants ?",
"position": 8,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les enfants peuvent présenter des symptômes respiratoires aigus ou chroniques."
}
},
{
"@type": "Question",
"name": "Comment la toux se manifeste-t-elle ?",
"position": 9,
"acceptedAnswer": {
"@type": "Answer",
"text": "La toux peut être sèche ou productive, selon la cause sous-jacente du poumon hyperclair."
}
},
{
"@type": "Question",
"name": "Le poumon hyperclair est-il asymptomatique ?",
"position": 10,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, il peut être asymptomatique, surtout dans les cas d'hyperinflation bénigne."
}
},
{
"@type": "Question",
"name": "Comment prévenir le poumon hyperclair ?",
"position": 11,
"acceptedAnswer": {
"@type": "Answer",
"text": "Éviter le tabagisme et les polluants environnementaux peut réduire les risques."
}
},
{
"@type": "Question",
"name": "Y a-t-il des vaccinations recommandées ?",
"position": 12,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, la vaccination contre la grippe et le pneumocoque est conseillée."
}
},
{
"@type": "Question",
"name": "Comment surveiller la santé pulmonaire ?",
"position": 13,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des examens réguliers et des tests de fonction pulmonaire sont recommandés."
}
},
{
"@type": "Question",
"name": "Les exercices respiratoires aident-ils ?",
"position": 14,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, ils peuvent améliorer la capacité pulmonaire et la santé respiratoire."
}
},
{
"@type": "Question",
"name": "Quelles habitudes de vie adopter ?",
"position": 15,
"acceptedAnswer": {
"@type": "Answer",
"text": "Adopter une alimentation équilibrée et faire de l'exercice régulièrement est bénéfique."
}
},
{
"@type": "Question",
"name": "Quel traitement pour un poumon hyperclair ?",
"position": 16,
"acceptedAnswer": {
"@type": "Answer",
"text": "Le traitement dépend de la cause sous-jacente, comme des bronchodilatateurs pour l'asthme."
}
},
{
"@type": "Question",
"name": "Les antibiotiques sont-ils nécessaires ?",
"position": 17,
"acceptedAnswer": {
"@type": "Answer",
"text": "Ils ne sont nécessaires que si une infection bactérienne est suspectée."
}
},
{
"@type": "Question",
"name": "Quand envisager une intervention chirurgicale ?",
"position": 18,
"acceptedAnswer": {
"@type": "Answer",
"text": "Une chirurgie peut être envisagée en cas de complications graves comme un pneumothorax."
}
},
{
"@type": "Question",
"name": "Les corticostéroïdes sont-ils efficaces ?",
"position": 19,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, ils peuvent être utilisés pour réduire l'inflammation dans certaines conditions."
}
},
{
"@type": "Question",
"name": "Comment gérer les symptômes respiratoires ?",
"position": 20,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des bronchodilatateurs et des thérapies respiratoires peuvent aider à soulager les symptômes."
}
},
{
"@type": "Question",
"name": "Quelles complications peuvent survenir ?",
"position": 21,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des complications comme le pneumothorax ou l'insuffisance respiratoire peuvent se produire."
}
},
{
"@type": "Question",
"name": "Le poumon hyperclair peut-il entraîner des infections ?",
"position": 22,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, une hyperinflation peut prédisposer à des infections pulmonaires."
}
},
{
"@type": "Question",
"name": "Comment gérer les complications ?",
"position": 23,
"acceptedAnswer": {
"@type": "Answer",
"text": "La gestion dépend de la complication, nécessitant parfois une hospitalisation."
}
},
{
"@type": "Question",
"name": "Le poumon hyperclair est-il réversible ?",
"position": 24,
"acceptedAnswer": {
"@type": "Answer",
"text": "Cela dépend de la cause; certaines conditions peuvent être réversibles avec un traitement."
}
},
{
"@type": "Question",
"name": "Quels sont les risques à long terme ?",
"position": 25,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les risques incluent une détérioration de la fonction pulmonaire et des complications chroniques."
}
},
{
"@type": "Question",
"name": "Quels sont les principaux facteurs de risque ?",
"position": 26,
"acceptedAnswer": {
"@type": "Answer",
"text": "Le tabagisme, l'exposition à des polluants et des antécédents familiaux de maladies respiratoires."
}
},
{
"@type": "Question",
"name": "L'âge influence-t-il le risque ?",
"position": 27,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, le risque augmente avec l'âge, surtout chez les fumeurs et les personnes exposées."
}
},
{
"@type": "Question",
"name": "Les maladies pulmonaires prédisposent-elles ?",
"position": 28,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des maladies comme l'asthme ou la BPCO augmentent le risque de poumon hyperclair."
}
},
{
"@type": "Question",
"name": "Le mode de vie joue-t-il un rôle ?",
"position": 29,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, un mode de vie sédentaire et une mauvaise alimentation peuvent augmenter le risque."
}
},
{
"@type": "Question",
"name": "Les allergies sont-elles un facteur ?",
"position": 30,
"acceptedAnswer": {
"@type": "Answer",
"text": "Certaines allergies respiratoires peuvent contribuer à des problèmes pulmonaires, y compris l'hyperclarté."
}
}
]
}
]
}
To explore the neuropsychological profile and the integrity of the olfactory network in patients with COVID-19-related persistent olfactory dysfunction (OD)....
Patients with persistent COVID-19-related OD underwent olfactory assessment with Sniffin' Sticks and neuropsychological evaluation. Additionally, both patients and a control group underwent brain MRI,...
We included 23 patients (mean age 37 ± 14 years, 12 females) with persistent (mean duration 11 ± 5 months, range 2-19 months) COVID-19-related OD (mean score 23.63 ± 5.32/48, hyposmia cut-off: 30.75) ...
Patients with persistent COVID-19-related OD showed an altered olfactory network connectivity correlated with hyposmia severity and neuropsychological performance. No significant morphological alterat...
Physical exercise is of great significance for maintaining human health. Exercise can provide varying degrees of benefits to cognitive function at all stages of life cycle. Currently, with the aging o...
Brain network models of cognitive control are central to advancing our understanding of psychopathology and cognitive dysfunction in schizophrenia. This review examines the role of large-scale brain o...
Several lines of evidence demonstrated the deleterious effect of methamphetamine (MA) on neurological and psychological functions. However, recent evidence on the neurological dysfunctions related to ...
Cognitive impairment of intellectual developmental disorders (IDD) is determined by several different combinations of specific cognitive alterations. People with IDD present a rate of mental health pr...
One hundred and twenty adults with mild to moderate IDD living in residential facilities underwent a clinical and instrumental assessment for specific cognitive and psychopathological features....
Participants with IDD and ASD have significantly lower scores compared to those without respect to who has not the diagnosis on the Processing Speed Index (PSI) and Perceptual Reasoning Index (PRI) on...
Although further research is needed, neuropsychological and IQ tests scores seem to be differently associated to various psychopathological conditions co-occurring with IDD, and with ASD especially. C...
Late effects such as neurocognitive issues and fatigue have been reported in childhood acute lymphoblastic leukemia (cALL) survivors. Yet, their association is often poorly understood. In this study, ...
Neurocognitive complications significantly reduce long-term health-related quality of life in patients undergoing liver transplantation; however, few studies have focused on their perioperative cognit...
This study included patients with end-stage liver disease who were on the liver transplantation waiting list. We performed an investigation with a neuropsychological battery before and 1 week after th...
A total of 132 patients completed all the investigations. Compared with healthy controls and preoperative cognitive performance, 54 patients experienced deterioration, 50 patients remained unchanged, ...
The incidences of deterioration, maintenance, and improvement in cognitive function were 40.9%, 37.9%, and 21.2%, respectively. Increasing age, higher MELD score, lower perfusion pressure in the early...
Post-COVID syndrome (PCS) is a medical condition characterized by the persistence of a wide range of symptoms after acute infection by SARS-CoV-2. The work capacity consequences of this disorder have ...
There is substantial evidence for the modulatory role of cyclic guanosine monophosphate (cGMP)-specific phosphodiesterases (PDEs) in memory and synaptic plasticity, and an increase in intracellular cG...
Coronavirus disease 2019 (COVID-19), caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), has led to a global pandemic. Although COVID-19 was initially described as a respiratory di...